-
Public Awareness and Perspectives on Respiratory Syncytial Virus Vaccination in Hong Kong: A Comprehensive Population-Based Study
Mar 10, 2025, 14:00 PM -
Real-World Evidence (RWE) in Health Technology Assessment (HTA): Global Guidelines on the Use of RWE in Evidence Generation for HTA Evaluation
Mar 10, 2025, 14:00 PM -
Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Leveraging CMS Medicare Data for Oncology RWE: Benefits, Limitations, and Opportunities, and Insights into Enrollment Patterns
Mar 10, 2025, 14:00 PM -
GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers
Mar 10, 2025, 14:00 PM -
Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab as Treatment for FIGO 2014 Stage III-IVA Cervical Cancer in the United States
Mar 10, 2025, 14:00 PM -
How Well Does Hospital Billing Data Estimate Readmissions and Revision Risks After Spinal Fusion Surgery, Compared to Hospital Billing Linked to Claims Data?
Mar 10, 2025, 14:00 PM -
Facilitating Effective Implementation of Qualitative in Trial Interviews
Mar 10, 2025, 14:00 PM -
Development of an Online Patient Decision Aid and Culturally Conscious Toolkit for Inflammatory Bowel Disease
Mar 10, 2025, 14:00 PM -
A Flexible Dynamic Transmission Model Framework for Evaluating Tuberculosis Treatments: Methodological Challenges and Applications
Mar 10, 2025, 14:00 PM -
Exploring the Impact of Exercise Variability of Mental Health: Results From the 2024 US National Health and Wellness Survey
Mar 10, 2025, 14:00 PM -
Integrating Next Generation Sequencing, EHR, and Claims Data to Extend Follow-Up in a Real-World Advanced Lung Adenocarcinoma Biomarker-Treatment Landscape
Mar 10, 2025, 14:00 PM -
Clinical Characteristics and Healthcare Resource Utilization Among Patients Initiating Semaglutide 2.4mg Versus Those Not Treated With Anti-Obesity Medications
Mar 10, 2025, 14:00 PM -
The Role of Invasive Diagnostics in Prior Authorization for MASH
Mar 10, 2025, 14:00 PM -
Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail
Mar 10, 2025, 14:00 PM -
Socioeconomic Value of Targeted Therapies for HER2+ Breast Cancer in National Reimbursement Drug List of China
Mar 10, 2025, 14:00 PM -
Integrating Patient-Reported Outcomes in Clinical Care: Opportunities and Roadblocks from the Clinician Perspective: A Scoping Review
Mar 10, 2025, 14:00 PM -
The Clinical Impact of Discontinuation of Sodium-Glucose Transport Protein 2 Inhibitors (SGLT2is): A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Factors Responsible for Successful Value-Based Agreements and Barriers for Their Adoption in the United States
Mar 10, 2025, 14:00 PM